Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc)- A Cost Utility Analysis from a Chinese Health Care Perspective
Abstract
Authors
G. Dranitsaris B. Yu Z. Qing J. King A. Zhang S. Kaura